Back
TCW Flexible Income ETF Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Sell
17
FLXR
TCW Flexible Income ETF
Last Price:
$39.49
Seasonality Move:
-1.33%
Sell
34
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.91
Seasonality Move:
-18.07%
Sell
17
TCW Flexible Income ETF (FLXR)
is a Sell
Is TCW Flexible Income ETF a Buy, Sell or Hold?
-
The current TCW Flexible Income ETF [FLXR] share price is $39.68. The Score for FLXR is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
FLXR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
34
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.96. The Score for INKT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FLXR Stock Price Chart
What is TCW Flexible Income ETF's stock price today?
-
The TCW Flexible Income ETF share price today is $39.68Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FLXR is experiencing buying pressure, which is a positive indicator for future bullish movement.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.96Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight selling pressure.
FLXR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 50.78 | Buy |
| Chaikin Money Flow: | 206564 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 47.65 | Sell |
| Chaikin Money Flow: | -11714 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.88 - 12.8) | Buy |
| Bollinger Bands (100): | (12.31 - 15.41) | Sell |
FLXR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.61 | Buy |
| 20-day SMA: | 39.67 | Buy |
| 50-day SMA: | 39.72 | Sell |
| 200-day SMA: | 39.4 | Buy |
| 8-day EMA: | 39.63 | Buy |
| 20-day EMA: | 39.66 | Buy |
| 50-day EMA: | 39.69 | Sell |
| 200-day EMA: | 39.47 | Buy |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.29 | Sell |
| 20-day SMA: | 11.54 | Buy |
| 50-day SMA: | 12.98 | Sell |
| 200-day SMA: | 11.84 | Buy |
| 8-day EMA: | 12.15 | Sell |
| 20-day EMA: | 12.09 | Sell |
| 50-day EMA: | 12.72 | Sell |
| 200-day EMA: | 12.23 | Sell |
TCW Flexible Income ETF Earnings Growth & FLXR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
TCW Flexible Income ETF Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||